MORE►
IPO
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
by Lance Murray | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
by Lance Murray |
Jul 18, 2024
Solera Corp., the Westlake-based global provider of SaaS solutions for the vehicle lifecycle ecosystem, announced in late June that it has filed a registration statement with the U.S....
MORE►
by Lance Murray |
Apr 2, 2024
Massimo Group, a Garland-based powersport vehicle company, said the IPO's proceeds are earmarked for several strategic initiatives aimed at expanding its business, including new products and electric vehicle-related technology.
MORE►
by David Seeley |
Dec 13, 2023
Two years after attempting to go public via a SPAC merger that valued it at $4.7 billion post-money, Apex is looking to do it the old-fashioned way with a direct SEC filing. The "fintech for fintechs" has more than 220 clients with over $115 billion in assets under custody, with 21 million brokerage accounts and active investors in 144 countries.
MORE►
Left to right: Perkins Coie partner Valeska Pederson Hintz, LiveOak Venture Partners partner Mike Marcantonio, and S3 Ventures partner Eric Engineer
DSW Dispatches: Investors Offer Tips on Navigating the Changing Startup Economy
by Kevin Cummings | Aug 11, 2022
At Dallas Startup Week today, three leading early-stage investors offered tips on how founders should pivot in today's shifting economy. Perkins Coie's Valeska Pederson Hintz, LiveOak Venture Partners’ Mike Marcantonio, and S3 Ventures' Eric Engineer shared insights and advice.
Despite the downturn, "If you've got a capital-efficient, growing business that has strong unit economics, at the end of the day that business is fundable, and that's what we're looking for," Marcantonio said.
MORE►
by Kevin Cummings |
Mar 29, 2022
Dallas-based Zimperium, a mobile security platform, is set to be acquired by Washington, D.C.’s Liberty Strategic Capital, a firm led by former Goldman Sachs CIO and Trump Administration appointee Steve Mnuchin.
MORE►
State of Entrepreneurship 2022: More Than $2 Billion Invested in North Texas Entrepreneurs Last Year
by Kevin Cummings |
Mar 14, 2022
It's the second year in a row to surpass $1 billion, said Trey Bowles at the Dallas Entrepreneur Center's annual State of Entrepreneurship event.
MORE►
by David Kirkpatrick |
Jan 12, 2022
Signify Health is walking the walk to making healthcare more accessible outside healthcare facility walls. This week, the company launched a new Partner Program with seven initial partners. The value-based ecosystem is focused on improving home healthcare through connecting hospitals, health systems, payers, and patients nationwide.
MORE►
The sale of Trammell Crow Center was the top DFW CRE deal for 2022. [Photo: Michael Samples]
Global Dermatology Innovator Galderma Moving U.S. Headquarters to Downtown Dallas
by Quincy Preston | Dec 10, 2021
One of the world's largest independent dermatology companies, Galderma's portfolio includes well-known brands such as Cetaphil, Proactiv, Differin, and Restylane. The Swiss company, whose ties to Texas date back to 1961, will call Trammell Crow Center in the Arts District home.
MORE►
by Alexandra Colman |
Nov 18, 2021
Although it may seem that going public is the finish line and the end of late-night phone calls and closed-door meetings, it also appears this is just the beginning.
sponsored by EisnerAmper
MORE►
by Alex Edwards |
Sep 13, 2021
The Plano-based fintech plans to expand its total addressable market and gain new cross-selling opportunities via the strategic acquisition.
MORE►
by Alex Edwards |
May 10, 2021
The combined company will have an anticipated market value of $491 million. "For the past few years our focus has been exponential growth, mainly in the North American market," the team told us. "The move to public market facilitates this even more."
MORE►
[Photo: Alkami]
Plano-Based Alkami Plans IPO Launch at $2B Valuation
by Alex Edwards | Apr 5, 2021
Alkami, under the ticker symbol ALKT, is looking to raise $141 million by selling 6 million shares of its common stock at an expected price of $22-25 per share.
MORE►
by Quincy Preston |
Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
by Quincy Preston and Alex Edwards |
Feb 23, 2021
Alkami, which was said to be "under the radar" in 2019, is reportedly planning for an IPO led by Goldman Sachs.
MORE►
by Alex Edwards |
Feb 11, 2021
The shares of the Dallas-based tech-enabled home healthcare provider opened at $32, higher than the original pricing of $24.
MORE►
